Poetter-Lang, Sarah
Bastati, Nina
Attenberger, Ulrike
Halilbasic, Emina
Trauner, Michael
Ba-Ssalamah, Ahmed https://orcid.org/0000-0002-3527-404X
Article History
Received: 18 August 2024
Revised: 18 August 2024
Accepted: 21 August 2024
First Online: 12 September 2024
Compliance with ethical standards
:
: The scientific guarantor of this publication is Dr. Ahmed Ba-Ssalamah.
: The authors of this manuscript declare relationships with the following companies: Sarah Poetter-Lang: nothing to disclose. Ahmed Ba-Ssalamah: honoraria for consulting from Bayer, speaker fees from Bayer and Siemens and Sanofi. This has no relation to this publication. Nina Bastati: nothing to disclose. Emina Halilbasic: nothing to disclose. Michael Trauner: received grant support from Albireo, Cymabay, Falk, Gilead, Intercept, MSD, and Takeda; honoraria for consulting from BiomX, Boehringer Ingelheim, Falk, Genfit, Gilead, Intercept, Janssen, MSD, Novartis, Phenex, and Regulus; speaker fees from BMS, Falk, Gilead, Intercept and MSD, as well as travel support from Abbvie, Falk, Gilead and Intercept.
: NA.
: Retrospective analysis, Informed Consent waived by IRB.
: Institutional Review Board approval was obtained. Ethics Commission (EC), Nr: 2249/2016 Radiologic Diagnosis of Cholestatic Liver Disease; A Retrospective Data Analysis.
: NA.
: